On May 24, 2018, the U.S. Food and Drug Administration (FDA) released a statement on GR2E Golden Rice, a rice genetically engineered to produce provitamin A carotenoids. The FDA statement concurs with the assessment of the International Rice Research Institute (IRRI) regarding the safety and nutrition of Golden Rice.

The FDA approval is the third positive food safety evaluation of Golden Rice, after the approvals granted by Food Standards Australia New Zealand (FSANZ) and Health Canada in February and March 2018, respectively.

The FDA statement concurred with the assessment of the International Rice Research Institute (IRRI) regarding the safety and nutrition of Golden Rice. The FDA approval is the third positive food safety evaluation of Golden Rice, after the approvals granted by Food Standards Australia New Zealand (FSANZ) and Health Canada in February and March 2018, respectively.